These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 16096169

  • 1. Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.
    Nguyên-Pascal ML, Thomas JL, Bergougnoux L, Garnero P, Drapier-Faure E, Delmas PD.
    Climacteric; 2005 Jun; 8(2):136-45. PubMed ID: 16096169
    [Abstract] [Full Text] [Related]

  • 2. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
    Murphy MG, Bach MA, Plotkin D, Bolognese J, Ng J, Krupa D, Cerchio K, Gertz BJ.
    J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
    [Abstract] [Full Text] [Related]

  • 3. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
    Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L.
    J Bone Miner Res; 2004 May; 19(5):737-44. PubMed ID: 15068496
    [Abstract] [Full Text] [Related]

  • 4. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
    Warming L, Ravn P, Christiansen C.
    Maturitas; 2005 Feb 14; 50(2):78-85. PubMed ID: 15653003
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S, D'Agosta S, Lombardo G.
    Minerva Ginecol; 2007 Jun 14; 59(3):205-14. PubMed ID: 17576399
    [Abstract] [Full Text] [Related]

  • 6. Effect of isoflavones on lipids and bone turnover markers in menopausal women.
    Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JA.
    Maturitas; 2004 Jul 15; 48(3):209-18. PubMed ID: 15207886
    [Abstract] [Full Text] [Related]

  • 7. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S, Caubel P, Garnero P, Felsenberg D.
    Maturitas; 2004 Jul 15; 48(3):197-207. PubMed ID: 15207885
    [Abstract] [Full Text] [Related]

  • 8. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
    Bunyavejchevin S, Limpaphayom KK.
    J Med Assoc Thai; 2001 Jan 15; 84(1):45-53. PubMed ID: 11281499
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR, Eastell R, Fogelman I, Adachi JD, Rosen A, Netelenbos C, Watts NB, Seeman E, Ciaccia AV, Draper MW.
    Arch Intern Med; 2004 Apr 26; 164(8):871-9. PubMed ID: 15111373
    [Abstract] [Full Text] [Related]

  • 10. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 26; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 11. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
    Uebelhart B, Herrmann F, Pavo I, Draper MW, Rizzoli R.
    J Bone Miner Res; 2004 Sep 26; 19(9):1518-24. PubMed ID: 15312253
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
    Savoca S, D'Agosta S, Lombardo G.
    Minerva Ginecol; 2007 Jun 26; 59(3):215-22. PubMed ID: 17576400
    [Abstract] [Full Text] [Related]

  • 13. The effect of low dose micronized 17ss-estradiol on bone turnover, sex hormone levels, and side effects in older women: a randomized, double blind, placebo-controlled study.
    Prestwood KM, Kenny AM, Unson C, Kulldorff M.
    J Clin Endocrinol Metab; 2000 Dec 26; 85(12):4462-9. PubMed ID: 11134094
    [Abstract] [Full Text] [Related]

  • 14. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW, Gluck OS, Lang E, Rakov V.
    Menopause; 2005 Dec 26; 12(6):741-8. PubMed ID: 16278618
    [Abstract] [Full Text] [Related]

  • 15. Three-year follow-up of the use of transdermal 17beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women.
    Delmas PD, Pornel B, Felsenberg D, Stakkestad JA, Radowicki S, Garnero P, Hardy P, Dain MP, Petitier B, International Study Group.
    Am J Obstet Gynecol; 2001 Jan 26; 184(2):32-40. PubMed ID: 11174476
    [Abstract] [Full Text] [Related]

  • 16. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
    Garnero P, Delmas PD.
    Ann Biol Clin (Paris); 1999 Jan 26; 57(2):137-48. PubMed ID: 10210740
    [Abstract] [Full Text] [Related]

  • 17. Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.
    García-Pérez MA, Moreno-Mercer J, Tarín JJ, Cano A.
    Gynecol Endocrinol; 2006 Apr 26; 22(4):179-84. PubMed ID: 16723303
    [Abstract] [Full Text] [Related]

  • 18. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.
    Hansdóttir H, Franzson L, Prestwood K, Sigurdsson G.
    J Am Geriatr Soc; 2004 May 26; 52(5):779-83. PubMed ID: 15086661
    [Abstract] [Full Text] [Related]

  • 19. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
    Choi HJ, Im JA, Kim SH.
    Maturitas; 2008 Jun 20; 60(2):170-6. PubMed ID: 18572334
    [Abstract] [Full Text] [Related]

  • 20. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC, Coutinho EM, Oladapo L, Noronha CF, Mota RL, Lopes AC, Lopes RC.
    Gynecol Endocrinol; 2009 Apr 20; 25(4):269-75. PubMed ID: 19408176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.